LOMBARD ODIER ASSET MANAGEMENT (SWITZERLAND) SA – CRISPR Therapeutics AG Transaction History
LOMBARD ODIER ASSET MANAGEMENT (SWITZERLAND) SA portfolio value:
$3.86M
portfolio value
LOMBARD ODIER ASSET MANAGEMENT (SWITZERLAND) SA quarter portfolio value change:
+7.54%
quarter
CRISPR Therapeutics AG 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -6.91% | -4.39K shares | 4K | $65.35 | 59.17K |
| Q2 2022 | share | Decrease | -66.66% | -127.11K shares | -8.10M | $60.77 | 63.56K |
| Q1 2022 | share | Increase | +7.27% | 12.91K shares | -1.50M | $62.77 | 190.68K |
| Q4 2021 | share | Increase | 0.00% | 177.76K shares | 13.47M | $78.85 | 177.76K |